Welcome to Markets Desk, here's what's moving the needle this Monday morning.
Meta Platforms and Tesla step into the earnings confessional this week carrying extra weight. A broad selloff in artificial intelligence names last week has investors on edge, and both companies now face pointed questions about whether their AI spending is translating into real returns or simply burning capital at scale.
That skepticism around AI spending has a direct read-through to Albemarle, though from an unexpected direction. The lithium producer has long been tethered to electric vehicle demand, and falling lithium prices punished it badly. But Wall Street is now identifying a new demand catalyst for the company's output, one that appears tied to energy storage for AI data centers, which could reframe the entire investment case.
Pulling back to the broader tape, Warren Buffett's cautionary signals on market valuations are drawing renewed attention from analysts. Despite that warning, some strategists argue select names in pharmaceuticals, including Pfizer, which is moving through a post-pandemic business transition faster than the market appreciates, still offer compelling value at current levels.
That's the tape. Markets Desk, signing off the floor.
